FFB News and Press Releases

  • Valproic acid, a drug which has shown promise for preserving vision in people affected by autosomal dominant forms of retinitis pigmentosa (adRP), is moving into a Foundation-funded multicenter clinical trial this fall.
  • Gene therapy has taken another major step forward as a treatment for retinal diseases. Researchers conducting the landmark gene therapy clinical trial at The Children’s Hospital of Philadelphia (CHOP) have just reported that 12 people with Leber congenital amaurosis have now been successfully treated and are experiencing sustained, and in many cases significant, improvement in their vision.

Pages